A Phase I Study of DX-8951f (Exatecan Mesylate for Injection) in Patients With Renal Dysfunction
Phase of Trial: Phase I
Latest Information Update: 21 May 2013
At a glance
- Drugs Exatecan (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 29 Oct 2007 Status changed from in progress to completed.
- 19 Sep 2005 New trial record.